Cargando…
Physiology-based toxicokinetic modelling of aluminium in rat and man
A sufficient quantitative understanding of aluminium (Al) toxicokinetics (TK) in man is still lacking, although highly desirable for risk assessment of Al exposure. Baseline exposure and the risk of contamination severely limit the feasibility of TK studies administering the naturally occurring isot...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380244/ https://www.ncbi.nlm.nih.gov/pubmed/34390355 http://dx.doi.org/10.1007/s00204-021-03107-y |
_version_ | 1783741161237643264 |
---|---|
author | Hethey, Christoph Hartung, Niklas Wangorsch, Gaby Weisser, Karin Huisinga, Wilhelm |
author_facet | Hethey, Christoph Hartung, Niklas Wangorsch, Gaby Weisser, Karin Huisinga, Wilhelm |
author_sort | Hethey, Christoph |
collection | PubMed |
description | A sufficient quantitative understanding of aluminium (Al) toxicokinetics (TK) in man is still lacking, although highly desirable for risk assessment of Al exposure. Baseline exposure and the risk of contamination severely limit the feasibility of TK studies administering the naturally occurring isotope (27)Al, both in animals and man. These limitations are absent in studies with (26)Al as a tracer, but tissue data are limited to animal studies. A TK model capable of inter-species translation to make valid predictions of Al levels in humans—especially in toxicological relevant tissues like bone and brain—is urgently needed. Here, we present: (i) a curated dataset which comprises all eligible studies with single doses of (26)Al tracer administered as citrate or chloride salts orally and/or intravenously to rats and humans, including ultra-long-term kinetic profiles for plasma, blood, liver, spleen, muscle, bone, brain, kidney, and urine up to 150 weeks; and (ii) the development of a physiology-based (PB) model for Al TK after intravenous and oral administration of aqueous Al citrate and Al chloride solutions in rats and humans. Based on the comprehensive curated (26)Al dataset, we estimated substance-dependent parameters within a non-linear mixed-effect modelling context. The model fitted the heterogeneous (26)Al data very well and was successfully validated against datasets in rats and humans. The presented PBTK model for Al, based on the most extensive and diverse dataset of Al exposure to date, constitutes a major advancement in the field, thereby paving the way towards a more quantitative risk assessment in humans. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-021-03107-y. |
format | Online Article Text |
id | pubmed-8380244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-83802442021-09-08 Physiology-based toxicokinetic modelling of aluminium in rat and man Hethey, Christoph Hartung, Niklas Wangorsch, Gaby Weisser, Karin Huisinga, Wilhelm Arch Toxicol Toxicokinetics and Metabolism A sufficient quantitative understanding of aluminium (Al) toxicokinetics (TK) in man is still lacking, although highly desirable for risk assessment of Al exposure. Baseline exposure and the risk of contamination severely limit the feasibility of TK studies administering the naturally occurring isotope (27)Al, both in animals and man. These limitations are absent in studies with (26)Al as a tracer, but tissue data are limited to animal studies. A TK model capable of inter-species translation to make valid predictions of Al levels in humans—especially in toxicological relevant tissues like bone and brain—is urgently needed. Here, we present: (i) a curated dataset which comprises all eligible studies with single doses of (26)Al tracer administered as citrate or chloride salts orally and/or intravenously to rats and humans, including ultra-long-term kinetic profiles for plasma, blood, liver, spleen, muscle, bone, brain, kidney, and urine up to 150 weeks; and (ii) the development of a physiology-based (PB) model for Al TK after intravenous and oral administration of aqueous Al citrate and Al chloride solutions in rats and humans. Based on the comprehensive curated (26)Al dataset, we estimated substance-dependent parameters within a non-linear mixed-effect modelling context. The model fitted the heterogeneous (26)Al data very well and was successfully validated against datasets in rats and humans. The presented PBTK model for Al, based on the most extensive and diverse dataset of Al exposure to date, constitutes a major advancement in the field, thereby paving the way towards a more quantitative risk assessment in humans. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-021-03107-y. Springer Berlin Heidelberg 2021-08-14 2021 /pmc/articles/PMC8380244/ /pubmed/34390355 http://dx.doi.org/10.1007/s00204-021-03107-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Toxicokinetics and Metabolism Hethey, Christoph Hartung, Niklas Wangorsch, Gaby Weisser, Karin Huisinga, Wilhelm Physiology-based toxicokinetic modelling of aluminium in rat and man |
title | Physiology-based toxicokinetic modelling of aluminium in rat and man |
title_full | Physiology-based toxicokinetic modelling of aluminium in rat and man |
title_fullStr | Physiology-based toxicokinetic modelling of aluminium in rat and man |
title_full_unstemmed | Physiology-based toxicokinetic modelling of aluminium in rat and man |
title_short | Physiology-based toxicokinetic modelling of aluminium in rat and man |
title_sort | physiology-based toxicokinetic modelling of aluminium in rat and man |
topic | Toxicokinetics and Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380244/ https://www.ncbi.nlm.nih.gov/pubmed/34390355 http://dx.doi.org/10.1007/s00204-021-03107-y |
work_keys_str_mv | AT hetheychristoph physiologybasedtoxicokineticmodellingofaluminiuminratandman AT hartungniklas physiologybasedtoxicokineticmodellingofaluminiuminratandman AT wangorschgaby physiologybasedtoxicokineticmodellingofaluminiuminratandman AT weisserkarin physiologybasedtoxicokineticmodellingofaluminiuminratandman AT huisingawilhelm physiologybasedtoxicokineticmodellingofaluminiuminratandman |